Department of Medicine Archive — Page 116 of 122

October 10, 2013

Probing mutant EGF receptor regulation

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

By Leigh MacMillan
ICU monitor and bed
October 3, 2013

Study finds cognitive deficits common after critical illness

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine.

By Craig Boerner
October 3, 2013

Framingham Heart Study’s landmark impact examined

While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease.

By Kathy Whitney
September 18, 2013

Fishing for new anti-cancer drugs

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

By Leigh MacMillan
September 5, 2013

Sarcoidosis research finds promising oral therapy

VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control.

By Wayne Wood
August 22, 2013

Gore, Bernard receive research awards at Faculty Assembly

“Vanderbilt’s Nobel Prize,” the Earl Sutherland Prize for achievement in research, was awarded to John Gore at the Fall Faculty Assembly, while Gordon Bernard received the Thomas Jefferson Award for distinguished service to Vanderbilt.

By Vanderbilt Health News